FTC Rules Impax $112mn Pay-For-Delay Deal With Endo Was Illegal

Agreeing a deal that it would not face an authorized generic during its 180-day market exclusivity for generic Opana ER contributed to Amneal's Impax striking an illegal pay-for-delay settlement, the FTC is alleging